How Can Women with Lean PCOS and Amenorrhea Restore Menstruation?

Women with polycystic ovary syndrome (PCOS) who are underweight or have low body weight—a less common but clinically significant phenotype—may experience secondary amenorrhea despite the absence of obesity. This presentation, sometimes referred to as “lean PCOS with amenorrhea,” reflects a distinct endocrine and metabolic profile that differs from the more prevalent overweight or obese PCOS subtype.

In lean individuals with PCOS, menstrual disturbances often stem from hypothalamic-pituitary-ovarian axis dysregulation rather than insulin resistance-driven hyperandrogenism alone. Contributing factors may include relative energy deficiency, low leptin levels, elevated cortisol, and altered gonadotropin-releasing hormone (GnRH) pulsatility—conditions that collectively suppress follicular development and prevent ovulation. Importantly, ovarian morphology on ultrasound may still show polycystic features (e.g., increased antral follicle count), fulfilling diagnostic criteria even in the absence of hyperandrogenic signs like hirsutism or acne.

Restoring menses in this population requires a multifaceted, individualized approach. First-line management emphasizes nutritional rehabilitation and weight stabilization—not weight loss—to correct energy availability and normalize neuroendocrine signaling. A registered dietitian specializing in reproductive endocrinology can help design a balanced, calorie-sufficient meal plan that supports hormonal recovery without promoting excessive adiposity.

When lifestyle interventions alone are insufficient, low-dose combined oral contraceptives (COCs) may be used short-term to induce withdrawal bleeding and provide endometrial protection. However, COCs do not address the underlying hypothalamic suppression and should not be viewed as definitive therapy. In select cases—particularly when fertility is desired—off-label use of letrozole or clomiphene citrate under specialist supervision may stimulate ovulation, though evidence specific to lean PCOS remains limited.

Comprehensive evaluation is essential before initiating treatment: serum tests for follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol, prolactin, thyroid-stimulating hormone (TSH), and anti-Müllerian hormone (AMH); pelvic ultrasound; and exclusion of other causes of amenorrhea, including functional hypothalamic amenorrhea, premature ovarian insufficiency, or hyperprolactinemia. Referral to a reproductive endocrinologist is strongly recommended for persistent amenorrhea or complex presentations.